Matricel GmbH

Collagen-based biomaterials for medical and biotechnological applications

Matricel also maintains cooperations with other companies focusing on novel treatment concepts in regenerative medicine such as peripheral nerve regeneration the treatment of injuries of the central nervous system, wound management, and orthopaedics.

Ingo Heschel, Dr., Managing Director
Leon Olde Damink, Dr., Production Manager
Frank Schügner, Engineering Manager
Lizette Eummelen, Quality Control

Kaiserstrasse 100
52134 Herzogenrath
Germany
Phone: +49-2407-5644-0
Fax: +49-2407-5644-10

Matricel has developed the CE-approved collagen-based scaffold (ACI-Maix™) for Collagen-covered Autologous Chondrocyte Implantation (CACI) and Matrix-guided Autologous Chondrocyte Implantation (MACI®). These innovative techniques were developed by Verigen AG for the treatment of articular cartilage defects.

The following section contains a selection of the company’s most relevant patents. For comprehensive patent information please refer to the espacenet databases.